Abstract
Using oral nitrates and phosphodiesterase type 5 inhibitors together can lead to abnormally low blood pressure, which in turn could cause harms such as syncope, stroke, and acute myocardial infarct... Visual Coprescription of Oral Organic Nitrates and PDE5 Inhibitors. Using oral nitrates and phosphodiesterase type 5 inhibitors together can lead to abnormally low blood pressure, which in... Background: Concomitant use of oral organic nitrates (nitrates) and phosphodiesterase type 5 (PDE5) inhibitors is contraindicated. Objective: To measure temporal trends in the coprescription of nit...
Funding Information
  • Dagmar Marshalls Fond
  • Snedkermester Sophus Jacobsen og Hustru Astrid Jacobsens Fond (J 167/1)
  • Marie og M.B. Richters Fond (2020-0379)
  • Ib Mogens Kristiansens Almene Fond (30206-383)
  • Helsefonden (20-B-0035)

This publication has 28 references indexed in Scilit: